Navigation Menu

Peder Olofsson Group

Peder Olofsson Group

Technology is changing the world and bioelectronic medicine is at the forefront of this technological revolution. The pharmaceutical industry's history is based on therapies that target molecular mechanisms, yet these therapies are expensive, difficult to administer, often toxic, and may be accompanied by lethal side effects. Bioelectronic medicine — the convergence of molecular medicine; neuroscience and biology; and electronics and computing to develop cures — may change the future of therapies for a wide variety of diseases. This groundbreaking discipline is aimed at interfacing electronics with nerves to specifically target the biological processes underlying disease. Bioelectronic medicine is now at the epicenter of where healthcare, technology, and science converge. A unique moment exists to characterize the challenges and opportunities facing the future of this scientific domain. 








If you would like to support this area of research

you could do that by using Swish transfer. 

Our Swish number is 123-245 79 76


Always state the name of group/team leader in order for us to allocate the gift properly. 

Or you can also use the following accounts:

BG: 628-4418
PG: 514114-8

Always state the name of group/team leader in order for us to allocate the gift properly. 

If you are outside of Sweden, please use the following information:

Bank: SEB, Stockholm, Sweden
Account No. 5201-11 370 12
Iban-number: SE16 5000 0000 0520 1113 7012
Bic-code (the bank´s electronic address): ESSESESS
Account holder: Center for Molecular Medicine Foundation
L8:05, Karolinska University Hospital
171 76 Stockholm, Sweden


Group leader

Peder Olofsson


Job title

Associate Professor, M.D.


BioClinicum J8:20



Circulation and respiration, Nerve-immune regulation


Aging, Animal models, Autoimmunity, Bioengineering, Cardiovascular, Cell culture, Electrophysiology, Flow cytometry, Gene expression, Immunohistochemistry, Innate immunity, Metabolism, Molecular, Neurosignalling, Pathology, Physiology, T-cells, Translational, Vaccines